Cavalier Investments, LLC Eli Lilly & CO Transaction History

Cavalier Investments, LLC

$318 Million
Q3 2024

A detailed history of Cavalier Investments, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cavalier Investments, LLC holds 32,556 shares of LLY stock, worth $26.3 Million. This represents 9.06% of its overall portfolio holdings.

Number of Shares

32,556

Previous 10,466 211.06%

Holding current value

$26.3 Million

Previous $9.48 Million 204.4%

% of portfolio

9.06%

Previous 2.98%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$772.14 - $960.02 $17.1 Million - $21.2 Million	22,090 Added 211.06%	32,556 $28.8 Million
Q2 2024 Aug 02, 2024	BUY	$724.87 - $909.04 $3.79 Million - $4.75 Million	5,225 Added 99.69%	10,466 $9.48 Million
Q1 2024 Apr 26, 2024	BUY	$592.2 - $792.28 $748,540 - $1 Million	1,264 Added 31.78%	5,241 $4.08 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $50,418 - $59,436	96 Added 2.47%	3,977 $2.32 Million
Q3 2023 Oct 23, 2023	BUY	$434.7 - $599.3 $681,609 - $939,702	1,568 Added 67.79%	3,881 $2.08 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $811,261 - $1.08 Million	2,313 New	2,313 $1.08 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $45,017 - $52,453	-140 Reduced 5.73%	2,305 $843,000
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $249,636 - $284,486	-842 Reduced 25.62%	2,445 $791,000
Q2 2022 Aug 04, 2022	SELL	$278.73 - $327.27 $660,590 - $775,629	-2,370 Reduced 41.89%	3,287 $1.07 Million
Q1 2022 May 04, 2022	SELL	$234.69 - $291.66 $232,577 - $289,035	-991 Reduced 14.91%	5,657 $1.62 Million
Q4 2021 Feb 02, 2022	SELL	$224.85 - $279.04 $86,342 - $107,151	-384 Reduced 5.46%	6,648 $1.84 Million
Q3 2021 Nov 02, 2021	BUY	$221.6 - $272.71 $1.56 Million - $1.92 Million	7,032 New	7,032 $1.63 Million

Others Institutions Holding LLY

# of Institutions

4,040

Shares Held

737M

Call Options Held

8.26M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $768B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cavalier Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cavalier Investments, LLC with notifications on news.

Account

Cavalier Investments, LLC Eli Lilly & CO Transaction History